| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,415 |
8,095 |
$1.38M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,066 |
5,830 |
$1.24M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,492 |
1,432 |
$489K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
645 |
633 |
$351K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
759 |
747 |
$325K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,463 |
1,401 |
$135K |
| 70450 |
Computed tomography, head or brain; without contrast material |
466 |
461 |
$92K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
66 |
66 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
539 |
425 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,529 |
2,405 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,681 |
1,592 |
$775.39 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,034 |
997 |
$635.89 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
670 |
637 |
$394.20 |
| 87631 |
|
1,128 |
1,107 |
$257.51 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,326 |
1,307 |
$247.38 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
580 |
569 |
$175.00 |
| 71046 |
Radiologic examination, chest; 2 views |
842 |
818 |
$168.43 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,011 |
977 |
$153.28 |
| 81025 |
|
2,162 |
2,101 |
$140.66 |
| 80053 |
Comprehensive metabolic panel |
4,192 |
3,931 |
$108.14 |
| 71045 |
Radiologic examination, chest; single view |
1,711 |
1,652 |
$101.32 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
985 |
951 |
$67.80 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
383 |
372 |
$51.31 |
| 73130 |
|
93 |
93 |
$49.78 |
| 80306 |
|
38 |
37 |
$27.28 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,133 |
3,919 |
$26.93 |
| 82803 |
|
191 |
183 |
$23.58 |
| 83605 |
|
199 |
183 |
$18.73 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,303 |
2,173 |
$16.77 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,085 |
2,001 |
$14.97 |
| 81003 |
|
2,803 |
2,704 |
$14.35 |
| 84484 |
|
841 |
783 |
$8.39 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
253 |
245 |
$7.15 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
195 |
187 |
$4.93 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
716 |
702 |
$4.58 |
| 82962 |
|
55 |
51 |
$3.25 |
| 82947 |
|
116 |
111 |
$2.19 |
| 73610 |
|
68 |
67 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,685 |
1,601 |
$0.00 |
| 84520 |
|
117 |
112 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
717 |
703 |
$0.00 |
| 90715 |
|
134 |
132 |
$0.00 |
| 84702 |
|
278 |
258 |
$0.00 |
| 80076 |
|
13 |
13 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
430 |
405 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
227 |
218 |
$0.00 |
| 73630 |
|
114 |
113 |
$0.00 |
| 74018 |
|
55 |
55 |
$0.00 |
| 73030 |
|
13 |
12 |
$0.00 |
| 87634 |
|
190 |
185 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
51 |
51 |
$0.00 |
| 73562 |
|
70 |
68 |
$0.00 |
| 82565 |
|
117 |
112 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
70 |
69 |
$0.00 |
| 87186 |
|
13 |
13 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
29 |
28 |
$0.00 |
| 93976 |
|
13 |
13 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
179 |
176 |
$0.00 |
| 82550 |
|
253 |
244 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
135 |
133 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
4,256 |
4,053 |
$0.00 |
| 82553 |
|
396 |
348 |
$0.00 |
| 80051 |
|
220 |
214 |
$0.00 |
| 85379 |
|
363 |
348 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
119 |
113 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
84 |
83 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
71 |
69 |
$0.00 |
| A9270 |
Non-covered item or service |
18 |
14 |
$0.00 |
| 87077 |
|
26 |
26 |
$0.00 |
| 87428 |
|
27 |
27 |
$0.00 |
| 84703 |
|
107 |
94 |
$0.00 |
| J3490 |
Unclassified drugs |
886 |
822 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
38 |
37 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
14 |
14 |
$0.00 |
| 96376 |
|
17 |
16 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$0.00 |
| 76801 |
|
25 |
24 |
$0.00 |